These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14584793)

  • 1. Cyclic phosphopeptides for interference with Grb2 SH2 domain signal transduction prepared by ring-closing metathesis and phosphorylation.
    Dekker FJ; de Mol NJ; Fischer MJ; Kemmink J; Liskamp RM
    Org Biomol Chem; 2003 Oct; 1(19):3297-303. PubMed ID: 14584793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain.
    Schoepfer J; Gay B; Caravatti G; Garcia-Echeverria C; Fretz H; Rahuel J; Furet P
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2865-70. PubMed ID: 9873638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs.
    Liu WQ; Vidal M; Olszowy C; Million E; Lenoir C; Dhôtel H; Garbay C
    J Med Chem; 2004 Feb; 47(5):1223-33. PubMed ID: 14971902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrocyclization in the design of a conformationally constrained Grb2 SH2 domain inhibitor.
    Gao Y; Voigt J; Wu JX; Yang D; Burke TR
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1889-92. PubMed ID: 11459654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
    Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
    J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides.
    Lee K; Zhang M; Liu H; Yang D; Burke TR
    J Med Chem; 2003 Jun; 46(13):2621-30. PubMed ID: 12801226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1).
    Ettmayer P; France D; Gounarides J; Jarosinski M; Martin MS; Rondeau JM; Sabio M; Topiol S; Weidmann B; Zurini M; Bair KW
    J Med Chem; 1999 Mar; 42(6):971-80. PubMed ID: 10090780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of thioether-bridged cyclic phosphopeptides binding to Grb2-SH2 domain.
    Li P; Peach ML; Zhang M; Liu H; Yang D; Nicklaus M; Roller PP
    Bioorg Med Chem Lett; 2003 Mar; 13(5):895-9. PubMed ID: 12617916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domain.
    Furet P; Gay B; García-Echeverría C; Rahuel J; Fretz H; Schoepfer J; Caravatti G
    J Med Chem; 1997 Oct; 40(22):3551-6. PubMed ID: 9357522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel peptide inhibitors for Grb2 SH2 domain and their detection by surface plasmon resonance.
    Lung FD; Tsai JY; Wei SY; Cheng JW; Chen C; Li P; Roller PP
    J Pept Res; 2002 Sep; 60(3):143-9. PubMed ID: 12213123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain.
    Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
    J Biomol NMR; 1997 Oct; 10(3):273-8. PubMed ID: 9390405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
    Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
    Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
    Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
    J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways.
    Fretz H; Furet P; Garcia-Echeverria C; Schoepfer J; Rahuel J
    Curr Pharm Des; 2000 Dec; 6(18):1777-96. PubMed ID: 11102562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for specificity switching of the Src SH2 domain.
    Kimber MS; Nachman J; Cunningham AM; Gish GD; Pawson T; Pai EF
    Mol Cell; 2000 Jun; 5(6):1043-9. PubMed ID: 10911998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrocyclization in the design of non-phosphorus-containing Grb2 SH2 domain-binding ligands.
    Shi ZD; Wei CQ; Lee K; Liu H; Zhang M; Araki T; Roberts LR; Worthy KM; Fisher RJ; Neel BG; Kelley JA; Yang D; Burke TR
    J Med Chem; 2004 Apr; 47(8):2166-9. PubMed ID: 15056012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain.
    Long YQ; Lung FD; Roller PP
    Bioorg Med Chem; 2003 Sep; 11(18):3929-36. PubMed ID: 12927853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant compensatory role of position Y-2 conferring high affinity to non-phosphorylated inhibitors of Grb2-SH2 domain.
    Long YQ; Voigt JH; Lung FD; King CR; Roller PP
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2267-72. PubMed ID: 10465559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.